跳至主要内容
临床试验/NCT03240991
NCT03240991已完成不适用

Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

Centre Hospitalier Universitaire de Besancon1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2016年7月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
1
主要终点
Dermatology Life Quality Index (DLQI)

研究概览

简要总结

This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired
  • Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III)

排除标准

  • Acquired angioedema with normal C1 inhibitor activity (former "drug-induced")
  • Minor subjects
  • Vulnerable subjects (under guardianship/curatorship/tutorship)
  • Pregnant women

结局指标

主要结局

Dermatology Life Quality Index (DLQI)

时间窗: 6 months

Description of Quality of Life (QoL) using DLQI

Angioedema Quality of Life (AE-QoL) Questionnaire

时间窗: 6 months

Description of QoL using AE-QOL questionnnaire

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study of Clinical, Biological Characteristics and... | 临床试验